Historique de carrière de Jerome Bailey
Anciens postes connus de Jerome Bailey
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LONGEVERON INC. | Directeur des opérations | 15/09/2022 | 01/04/2024 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formation de Jerome Bailey
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Jerome Bailey
- Expérience
